Vaccines

COVID-19 Vaccines COVID-19 Respiratory Syncytial Virus (RSV) Covid Vaccines RSV Vaccine Respiratory Syncytial Virus COVID-19 Vaccine AstraZeneca Covid Vaccine mRNA Vaccines Covid-19 Vaccines Vaccine Development Vaccine Safety Influenza Vaccine RSV Vaccines MMR Vaccine mRNA Technology mRNA-based Vaccines Preventive Medicine Mpox Vaccine Types of Vaccines Biotech Industry Dengue Vaccines Childhood Vaccination Production Facilities Vaccine Skepticism Vaccines for Children Program Safety Flu Vaccine Covid-19 Malaria Vaccine Coronavirus Vaccines Combination Vaccines Flu vaccine Healthcare Views Anti-Vaccine Conspiracy Theories Measles Infectious Diseases Malaria Coronavirus Vaccine Tests Pharmaceutical Industry Biotechnology Operation Warp Speed Skin Cancer Clinical Trials Adverse Reactions Comparison Studies mRNA-1083 Combined Vaccines Production Capacity Pneumococcal Vaccines HPV Vaccine Dengue Vaccine Respiratory Diseases H5N1 Vaccine

Pfizer Reports Strong Q4 Earnings But Faces Uncertain Market Sentiment

Pfizer Exceeds Q4 Earnings Expectations with Strong Covid Product Sales and Cost Cuts

AstraZeneca Cancels £450m UK Vaccine Plant Expansion Over Funding Dispute

Trust in U.S. Public Health Agencies Declines as RFK Jr. Faces Confirmation Hearings

New XEC COVID Variant Emerges in UK, Raising Hospitalisation Rates

New COVID Surge and Updated Vaccines Prompt Renewed Precautions

Moderna Secures $176M to Develop mRNA Bird Flu Vaccine

CDC Recommends Updated Vaccines for Fall 2024

CDC Updates RSV Vaccine Guidance for Older Adults

NHS to Offer RSV Vaccine to Pregnant Women and Elderly This Autumn

FDA Approves Merck's New Adult Pneumococcal Vaccine Capvaxive

Moderna's COVID-Flu Combo Vaccine Shows Strong Results in Phase 3 Trials

FDA Approves Moderna's mRNA RSV Vaccine for Older Adults

First US Lawsuit Filed Against AstraZeneca by Vaccine Trial Participant

Moderna Reports Sharp Decline in COVID-19 Vaccine Sales, Outperforms Expectations

Moderna Posts Large Q3 Loss With Weaker Vaccine Demand, Projects $4B in Sales for 2024, Investors Concerned

Vaccine rollout faces insurance, supply hurdles

Moderna Reports Quarterly Loss But Raises COVID Vaccine Sales Outlook Despite Waning Demand

Former Republican Senator Lowell Weicker, Nixon Critic and Bold Political Maverick, Dies at 92

Walgreens stock slumps as pandemic profits fall flat